Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Merck Serono Launches Glucophage Powder in EU | Contract Pharma

What are you searching for?

Sign in
Breaking News, Trials & Filings

Merck Serono Launches Glucophage Powder in EU

Merck Serono, a division of Merck KGaA, has launched Glucophage Powder for Oral Solution in Sachets, indicated for the first-line treatment of type 2 diabetes mellitus, in France and the UK.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Merck Serono, a division of Merck KGaA, has launched Glucophage Powder for Oral Solution in Sachets, indicated for the first-line treatment of type 2 diabetes mellitus, in France and the UK. Marketing authorizations in other European countries for the new formulation of Glucophage are expected in the coming months.

The new powder formulation is bioequivalent to the existing Glucophage tablets and is packaged in individual sachets of 500mg, 850mg and 1000mg. Glucophage powder dissolves in water.

“Adherence to therapy is increasingly being recognized by physicians as a key condition to achieve glycemic control for patients with diabetes,” said Roberto Gradnik, executive vice president commercial Europe at Merck Serono. “We are pleased to provide this innovative powder formulation of Glucophage to patients seeking a convenient alternative to tablets which may facilitate their adherence to treatment.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters